These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Updates from the 18th National Immunization Conference for Health Care Workers: Manchester Conference Centre, December 2007. Guppy MJ; Baxter DN Hum Vaccin; 2009 May; 5(5):284-90. PubMed ID: 19077537 [TBL] [Abstract][Full Text] [Related]
3. Next generation vaccines. Riedmann EM Hum Vaccin; 2011 Jul; 7(7):718-22. PubMed ID: 22002157 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy and vaccination after transplant: the present, the future. Emery VC; Einsele H; Atabani S; Haque T Infect Dis Clin North Am; 2010 Jun; 24(2):515-29. PubMed ID: 20466281 [TBL] [Abstract][Full Text] [Related]
5. [Vaccination--turned from its head to its feet]. Malinverni R Ther Umsch; 2005 Oct; 62(10):663-4. PubMed ID: 16277032 [No Abstract] [Full Text] [Related]
6. Vaccine strategies for glioblastoma: progress and future directions. Jackson C; Ruzevick J; Brem H; Lim M Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in Toxoplasma gondii immunotherapeutics. Lim SS; Othman RY Korean J Parasitol; 2014 Dec; 52(6):581-93. PubMed ID: 25548409 [TBL] [Abstract][Full Text] [Related]
9. Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference. Wiysonge CS; Waggie Z; Hawkridge A; Schoub B; Madhi SA; Rees H; Hussey G Pan Afr Med J; 2016; 23():53. PubMed ID: 27217879 [TBL] [Abstract][Full Text] [Related]
10. Report of the 2nd "French Clinical Vaccinology Meeting Jean-Gerard Guillet": immunization and respiratory diseases. Loulergue P; Burgel PR; Carrat F; Fritzell B; Guthmann JP; Locht C; Power UF; Varon E; Dusser D; Launay O Vaccine; 2010 Sep; 28(40):6551-5. PubMed ID: 20674881 [TBL] [Abstract][Full Text] [Related]
11. Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes. Johnson MC; Wang B; Tisch R Hum Vaccin; 2011 Jan; 7(1):27-36. PubMed ID: 21157183 [TBL] [Abstract][Full Text] [Related]
12. Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes. Keselowsky BG; Xia CQ; Clare-Salzler M Hum Vaccin; 2011 Jan; 7(1):37-44. PubMed ID: 21157186 [No Abstract] [Full Text] [Related]
13. ASVAC2019: 7th Asian Vaccine Conference. Linn K; Bravo L; Goh DYT; Nelson EAS Hum Vaccin Immunother; 2020 Jul; 16(7):1476-1484. PubMed ID: 31765270 [TBL] [Abstract][Full Text] [Related]
14. First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines. Borriello F; van Haren SD; Levy O mSphere; 2018 Aug; 3(4):. PubMed ID: 30068557 [TBL] [Abstract][Full Text] [Related]
16. Transforming biomedical research to develop effective TB vaccines: the next ten years. Sizemore CF; Fauci AS Tuberculosis (Edinb); 2012 Mar; 92 Suppl 1():S2-3. PubMed ID: 22441154 [No Abstract] [Full Text] [Related]
17. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK. Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304 [TBL] [Abstract][Full Text] [Related]
18. HIV immunotherapy comes of age: implications for prevention, treatment and cure. Routy JP; Mehraj V; Cao W Expert Rev Clin Immunol; 2016; 12(2):91-4. PubMed ID: 26629806 [TBL] [Abstract][Full Text] [Related]